Bluejay Diagnostics, Inc.
Bluejay Diagnostics, Inc.（BJDX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · BJDX · 截至 2026年6月9日
活动摘要
买入笔数
6
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
Bluejay Diagnostics, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
BJDX 季度内部人买卖趋势
BJDX 内幕交易卖出 · BJDX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · BJDX CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
BJDX 高管卖出股份 · BJDX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 14, 2026 | Wurth Douglas Clark Director | Purchase | 12,500 | $25K | Form 4 |
| Mar 14, 2026 | Dey Indranil President and CEO · Director | Purchase | 12,500 | $25K | Form 4 |
| Mar 14, 2026 | CHASE DONALD R Director | Purchase | 12,500 | $25K | Form 4 |
| Mar 14, 2026 | ZEIDMAN FRED S Director | Purchase | 12,500 | $25K | Form 4 |
| Mar 14, 2026 | Dey Svetlana Director | Purchase | 12,500 | $25K | Form 4 |
| Dec 13, 2023 | Dey Svetlana Director | Purchase | 500 | $2K | Form 4 |
| Dec 13, 2023 | Dey Indranil President and CEO · Director | Purchase | 500 | $2K | Form 4 |
| Mar 28, 2023 | Dey Indranil President and CEO · Director | Award | 2,000 | $880 | Form 4 |
| Mar 27, 2023 | Dey Indranil President and CEO · Director | Award | 8,000 | $4K | Form 4 |
| Mar 24, 2023 | Dey Svetlana Director | Award | 10,000 | $4K | Form 4 |
| Feb 1, 2023 | Gemignani Gary G Director | Award | 27,500 | $12K | Form 4 |
| Feb 1, 2023 | CHASE DONALD R Director | Award | 27,500 | $12K | Form 4 |
| Feb 1, 2023 | Dey Svetlana Director | Award | 27,500 | $12K | Form 4 |
| Feb 1, 2023 | Dey Indranil President and CEO · Director | Award | 159,090 | $70K | Form 4 |
| Feb 1, 2023 | Dey Indranil President and CEO · Director | Other | 55,612 | $24K | Form 4 |
| Feb 1, 2023 | Fisher Kenneth R CFO | Award | 112,500 | $50K | Form 4 |
| Feb 1, 2023 | Fisher Kenneth R CFO | Other | 39,316 | $17K | Form 4 |
| Feb 1, 2023 | ZEIDMAN FRED S Director | Award | 27,500 | $12K | Form 4 |
| Feb 1, 2023 | Wurth Douglas Clark Director | Award | 27,500 | $12K | Form 4 |
| Aug 26, 2022 | Fisher Kenneth R Director | Purchase | 20,000 | $21K | Form 4 |
| Apr 25, 2022 | Fisher Kenneth R CFO | Purchase | 20,000 | $20K | Form 4 |
| Mar 17, 2022 | Kinder Gordon Winston CFO | Purchase | 2,500 | $3K | Form 4 |
| Mar 17, 2022 | Dey Svetlana Director | Purchase | 10,000 | $12K | Form 4 |
| Mar 17, 2022 | Wurth Douglas Clark Director | Purchase | 40,000 | $47K | Form 4 |
| Mar 16, 2022 | Wurth Douglas Clark Director | Purchase | 60,000 | $65K | Form 4 |
Dey Indranil
President and CEO · Director
日期
Mar 14
股数
12,500
均价
$2.00
总金额
$25K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 BJDX 内幕交易
BJDX 内幕交易
Bluejay Diagnostics, Inc.（BJDX）内幕交易数据来源于公司内部人（包括Wurth Douglas Clark (Director), Dey Indranil (President and CEO · Director), CHASE DONALD R (Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。BJDX内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Bluejay Diagnostics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
BJDX 内幕交易 · 5个问题Bluejay Diagnostics, Inc.（BJDX）的内部人包括高管和董事，如Wurth Douglas Clark (Director), Dey Indranil (President and CEO · Director), CHASE DONALD R (Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026